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In addition to providing lipid chains for protein prenylation, short-chain isoprenyl diphosphate 
synthases (scIPPSs) play a pivotal role in the biosynthesis of numerous mevalonate pathway end-
products, including insect juvenile hormone and terpenoid pheromones. For this reason, they are being 
considered as targets for pesticide development. Recently, we characterized an aphid scIPPS displaying 
dual geranyl diphosphate (GPP; C10)/farnesyl diphosphate (FPP; C15) synthase activity in vitro. To 
identify the mechanism(s) responsible for this dual activity, we assessed the product selectivity of aphid 
scIPPSs bearing mutations at Gln107 and/or Leu110, the fourth and first residue upstream from the “first 
aspartate-rich motif” (FARM), respectively. All but one resulted in significant changes in product chain-
length selectivity, effectively increasing the production of either GPP (Q107E, L110W) or FPP (Q107F, 
Q107F–L110A); the other mutation (L110A) abolished activity. Although some of these effects could be 
attributed to changes in steric hindrance within the catalytic cavity, molecular dynamics simulations 
identified other contributing factors, including residue-ligand Van der Waals interactions and the 
formation of hydrogen bonds or salt bridges between Gln107 and other residues across the catalytic 
cavity, which constitutes a novel product chain-length determination mechanism for scIPPSs. Thus the 
aphid enzyme apparently evolved to maintain the capacity to produce both GPP and FPP through a 
balance between these mechanisms. 
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Isoprenoids form a very large family of compounds that play essential roles in numerous 
biochemical pathways, e.g. as components of electron carriers, as cell membrane constituents, in 
subcellular targeting and regulation, as hormones, as well as serving in communication and defense in 
plants and insects. Because isoprenoids are often involved in life-dependent processes, some of the 
enzymes responsible for their biosynthesis have been used as targets for the development of drugs (e.g., 
statins, bisphosphonates) and herbicides (Cromartie et al. 1999), and some are being considered as targets 
for insecticide design (Cusson et al. 2006; Palli and Cusson 2007; Vandermoten et al. 2008b; 
Vandermoten et al. 2009).  
Isoprenoids generated by the mevalonate pathway are built through a common biosynthetic 
mechanism in which the C5 dimethylallyl diphosphate (DMAPP) undergoes a 1'-4 condensation with its 
homoallylic isomer, isopentenyl diphosphate (IPP), to form geranyl diphosphate (GPP, C10), which may 
then undergo additional condensations with IPP to yield longer products such as farnesyl diphosphate 
(FPP, C15) and geranylgeranyl diphosphate (GGPP, C20). Generally, each of these diphosphates is 
generated by a specific short-chain isoprenyl diphosphate synthase (scIPPS; also referred to as 
“prenyltransferase”) named according to its final product: geranyl diphosphate synthase (GPPS), farnesyl 
diphosphate synthase (FPPS), and geranylgeranyl diphosphate synthase (GGPPS) (Bellés et al. 2005). 
Site-directed and random mutagenesis studies aimed at scIPPSs (Ohnuma et al. 1996a; Ohnuma et 
al. 1996b; Tarshis et al. 1996; Ohnuma et al. 1997; Narita et al. 1999; Fernandez et al. 2000; Kawasaki et 
al. 2003), combined with the elucidation of their 3D structures (Tarshis et al. 1994; Kavanagh et al. 
2006a; Kavanagh et al. 2006b), have provided insights into the mechanism of product chain-length 
determination (Liang et al. 2002). Several studies demonstrated that the product chain length of wild-type 
(WT) FPPSs and GGPPSs is in large part determined by the nature of the amino-acid residues located at 
the fourth and fifth positions upstream from the “first aspartate-rich motif” (FARM), a well conserved 
motif among scIPPSs (Ohnuma et al. 1996a; Ohnuma et al. 1996b; Tarshis et al. 1996; Narita et al. 1999). 
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The side-chains of these amino-acid residues can either prevent or allow additional condensations to take 
place, with smaller side-chains typically permitting further product elongation. 
Residues other than those at positions –4 and –5 relative to the FARM may also play a role in the 
chain length selectivity of these prenyltransferases. For example, the Ala116Trp (–1 relative to the 
FARM) and Asn144Trp (+23 relative to the FARM) avian FPPS mutants displayed a smaller binding 
pocket for the hydrocarbon chain of the allylic substrate, with altered product selectivity favoring 
synthesis of shorter products such as GPP (Fernandez et al. 2000; Vandermoten et al. 2008a). In yeast 
GGPPS, in which a Ser residue occupies both the fourth and fifth positions upstream from the FARM, 
other residues located on distinct α-helices and deeper within the catalytic cavity prevent chain elongation 
beyond C20 (Chang et al. 2006). 
Here we follow up on an earlier study in which we provided the evidence for an aphid 
prenyltransferase displaying dual GPP/FPP synthase activity (Vandermoten et al. 2008a), a finding that 
was corroborated by an independent study (Lewis et al. 2008). In an effort to determine whether the aphid 
enzyme was unique to the aphid species from which we originally cloned it, the green peach aphid, Myzus 
persicae, we undertook the cloning of its cDNA from the pea aphid, Acyrthosiphon pisum. Production of 
the recombinant A. pisum ortholog (ApIPPS) and analysis of its catalytic properties revealed the same 
dual GPP/FPP synthase activity found for the M. persicae enzyme (MpIPPS). To identify the mechanism 
responsible for this dual activity, both in vitro and in silico studies were performed. These analyses 
provide new insights into the product chain-length determination mechanism of scIPPSs.  
 
MATERIAL AND METHODS 
Cloning and sequencing of ApIPPS cDNA.  Cloning of an ApIPPS cDNA was carried out using 
the same PCR strategy employed for the cloning of MpIPPS cDNAs (for primer sequences, see 
Supplemental Table 1). The complete coding region of ApIPPS was cloned into the pGEM-T Easy vector 
(Promega) and then into the expression vector pET-30b (Novagen) after amplification by PCR, using 
specific primers to introduce EcoRI and XhoI restriction sites at the 5’ and 3’ ends, respectively.  
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Site-directed mutagenesis of ApIPPS.  Mutagenesis was performed on pGEM-T Easy vector 
(Promega) containing the ApIPPS coding region with EcoRI and XhoI restriction sites at the 5’ and 3’ 
ends, respectively. Site-specific mutations were introduced using the GeneTailor site-directed 
mutagenesis system (Invitrogen) (for primer sequences, see Supplemental Table 1). After mutations were 
introduced into target sites and confirmed by sequencing, the mutated coding regions contained between 
the EcoRI and XhoI restriction sites were ligated into the pET30b vector. Fidelity of each insert was 
confirmed by sequencing. 
Overproduction and purification of recombinant proteins. Each construct for expression of a 
protein mutant was introduced into E. coli strain BL21 (DE3). The procedures used for expression and 
purification of ApIPPS mutant and WT enzymes were as described (Vandermoten et al. 2008a). Purity of 
the mutant enzymes was assessed by SDS-PAGE, and protein concentration was determined by the 
microassay procedure of the Bio-Rad Protein Assay, using BSA as standard.  
Prenyltransferase assay and product analysis. Enzyme assays were conducted in the presence of 
DMAPP and [14C]IPP as subtrates, and the nature of products formed in vitro by each recombinant 
protein was determined by HPLC/LSC analysis of hydrolized products as described (Vandermoten et al. 
2008a). Proportions of GPP and FPP produced were calculated on the basis that they incorporate 1 and 2 
units of [14C]IPP, respectively; in our previous report (Vandermoten et al. 2008a), the proportions 
presented were simply calculated from the total radioactivity associated with each product. Given that all 
assays were carried out at five different DMAPP concentrations and that increasing DMAPP 
concentrations had the same effect on product distribution with WT and mutant proteins (Supplemental 
Fig. 3), these assays were used as an indirect form of replication. 
Molecular dynamics simulations. Homodimeric 3D models corresponding to the ApIPPS WT 
sequence (residues 15-362) were built using MODELLER (Sali and Blundell 1993) as previously 
described (Vandermoten et al. 2008a) to serve as initial structures for the molecular dynamics 
simulations. Models without ligand or with DMAPP, GPP or FPP were constructed using the appropriate 
PDB avian structures as templates (PDB ID codes: 1UBV, 1UBX, 1UBY, and 1UBW, respectively) 
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(Tarshis et al. 1994; Tarshis et al. 1996). All models were successfully validated with PROCHECK 
(Laskowski et al. 1993), which was not surprising given the high level of sequence similarity (48% of 
sequence identity and only two single residue indels in coil regions that are not involved in the formation 
of the catalytic site). The molecular dynamics simulation protocol was similar to the one used by (Santini 
et al. 2009). Briefly, DMAPP, GPP and FPP coordinates were submitted to the PRODRG server 
(Schuettelkopf and van Aalten 2004) to generate topologies adapted by hand to the G43a2 version of  
GROMOS96 (Schuler et al. 2001). Each homodimer complexed with 4 Mg2+ ions and ligands was 
included in a triclinic box (9 x 11 x 9 nm) and filled with approximately 26,000 simple-point-charge 
water molecules. The systems were neutralized with Na+ ions at the most favorable places, then 
minimized by 2000 steps of steepest descent and 1000 steps of conjugate gradient using the GROMACS 
software (Berendsen et al. 1995). The electrostatic interactions were treated with the PME method 
(Essmann et al. 1995) and the Van der Waals interactions with the shift method. 1.2 nm cut-offs were 
applied. 
The minimized systems were submitted to 50 ps heating runs at 300 K under position restraints on 
protein heavy atoms, Mg2+ ions and ligand atoms, and then to 4 ns runs without restraints. Temperature 
and pressure (1 bar) were maintained using the bath method (Berendsen et al. 1984). Bonds were 
maintained with the LINCS algorithm (Hess et al. 1997). 
Analysis of the molecular dynamics trajectories. Root Mean Square Deviations (RMSD) were 
computed over the 4 ns of the runs using the initial structure as reference. In the light of these results, the 
first 500 ps of each run were considered as the equilibration phase of the simulations and were not taken 
into account for the rest of the analyses (Supplemental Figure 1). The Root Mean Square Fluctuations 
(RMSF) were computed similarly for each Cα atom. 
Interaction energies along the trajectories were estimated for both electrostatic and Van der Waals 
terms between the groups of atoms under investigation. For each structure, the number of contacts 
between the residue at position 110 and the ligand was defined as the number of pairs of atoms that have 
their mass center at less than 0.5 nm from each other. This number was computed using the g_mindist 
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subroutine within the GROMACS package. The same routine was used to determine the minimum 
distance between residue 110 and the ligand. Hydrogen bonds were determined using the g_hbond 
subroutine, with default parameters. H-bonds between the residue at position 107 and T172, T75, Q179 or 
K209 were classified as “crossing” H-bonds after visual inspection of the 3D models and trajectories. 
Since all simulations were done with dimers, the two monomers were regarded as repetitions, 
making the assumption that the molecular mechanisms in each pocket are independent of one another. For 
each variable measured, the calculations were performed on each monomer individually. Single average 
and standard deviation values were then calculated from 0.5 to 4 ns, combining the two monomers. 
For molecular visualization, we used both PYMOL (deLano 2002) and VMD software (Humphrey 
et al. 1996). All 3D images were generated with PYMOL. Residues are numbered with respect to the WT 
sequence of ApIPPS. 
 
RESULTS 
Cloning of A. pisum IPPS. A full-length cDNA encoding a scIPPS was isolated from our A. pisum 
cDNA library (Genbank accession no. AY968585); the predicted protein (ApIPPS) showed a high level 
of sequence identity (97%) with MpIPPS1-L (Genbank accession no. AAY33491), including the presence 
of a Gln residue at the fourth position upstream from the FARM (Fig. 1A and Supplemental Figure 2). 
ApIPPS displayed the same dual GPP/FPP synthase activity reported for MpIPPS (Vandermoten et al. 
2008a), with increasing concentrations of DMAPP leading to rising proportions of the GPP product (Fig. 
1B). The splice variant that we cloned contained an N-terminal mitochondrial targeting peptide almost 
identical to that found in MpIPPS1-L, the presence of which was shown to impair enzymatic activity 
(Vandermoten et al. 2008a). Therefore, only the short form of ApIPPS (e.g., the mature protein without 
the targeting peptide) was used in the present assays and analyses. 
Design of mutated ApIPPS and analysis of in vitro end-products. Comparison of the ApIPPS 
and avian FPPS active sites led to the identification of two amino acid residues that could be responsible, 
either alone or in combination, for the dual activity of the aphid enzyme: Gln107 and Leu110 
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(Vandermoten et al. 2008a). We predicted the existence of two distinct regulatory mechanisms involving 
the residues at each of these two positions: (i) a mechanism involving hydrogen bonds for position 107 
and (ii) a mechanism involving steric hindrance for position 110. Therefore, we constructed five ApIPPS 
mutants by means of site-directed mutagenesis: Q107F, Q107E, L110A, L110W, and Q107F-L110A. For 
each position, one substitution was chosen to decrease the putative constraint of the residue on product 
chain length (Q107F, L110A), while the other was selected to increase it (Q107E, L110W). The 
substitutions in the double mutant were chosen to mimic the chicken enzyme, thereby allowing us to 
determine whether the residues at these two positions could entirely account for the uncommon properties 
of the aphid enzyme.  
With the exception of L110A, all mutant enzymes presented a product profile in agreement with the 
initial predictions based on the homology models (Vandermoten et al. 2008a). The average IPP 
conversion rates for all DMAPP concentrations combined were generally high for WT (95%) and mutant 
proteins (82% for Q107E; 97% for Q107F; and 97% for Q107F-L110A), with the exception of the 
L110W mutant, which displayed a conversion rate of 52% and the L110A mutant, which failed to show 
any detectable activity.  
Significant changes in product selectivity were observed for each mutant, with individual proteins 
falling into one of two categories: (i) those that formed greater amounts of GPP (Q107E and L110W) and 
(ii) those that formed greater amounts of FPP (Q107F and Q107F-L110A) than the wild-type ApIPPS 
(Fig. 1C). In addition, the mutated enzymes generally displayed a DMAPP-concentration-dependent 
effect similar to that observed for the WT enzyme (Supplemental Figure 3). However, DMAPP 
concentration had a far smaller impact on product chain-length selectivity than the mutations. 
Investigation of the ApIPPS-ligand interactions by molecular dynamics simulations. To gain 
insight into the molecular mechanisms involved in the regulation of the IPPS end-product chain length, 
we performed 4 ns molecular dynamics simulations on 3D models of all mutants, without ligand or with 
DMAPP, GPP, or FPP. To assess the validity of the simulations, we verified the stability of the system 
(protein-ligand) along the trajectories. We therefore examined the total energy of the system, the RMSD 
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of the protein Cα atoms, and their RMSF. Altogether, these preliminary analyses demonstrated the 
validity of the simulations, which should represent a good quality sample of the conformational space (see 
Supplemental Figure 1 for a full report on these analyses). Furthermore, they indicated that both WT and 
mutant protein structures tend to stabilize after the first 500 ps and could thus be subjected to more 
detailed analyses during the remaining 3.5 ns of the simulations. We then turned our attention to the 
impact of substitutions at positions 110 and 107 on the product chain length selectivity of the enzyme. 
Interactions between the residue at position 110 and the ligand. By substituting Trp or Ala for 
Leu at position 110 (Leu, Ala or Trp; referred to here as X110), we aimed to increase or decrease the 
steric hindrance within the active site and thus favor the production of shorter or longer products, 
respectively. To assess this effect, we first calculated the minimum distance between the X110 residue 
and the ligand. In the presence of DMAPP, greater distances were observed when an Ala residue was 
present at position 110 (e.g., L110A and Q107F-L110A mutants), although differences with other 
proteins were not significant except for the L110W mutant (Fig. 2A). Sharper differences were observed 
in the presence of GPP, with the minimum distance to the Ala residue in the L110A mutant being ~0.24 
nm greater than that calculated for the Leu residue in the WT, and Q107F and Q107E mutants; not 
surprisingly, this difference was even greater between the L110A and L110W mutants (Fig. 2A), 
reflecting the fact that GPP and the Trp residue almost made steric clashes. The double mutant displayed 
an intermediate profile and greater variability. No significant differences were observed for this variable 
among the FPP-liganded structures (Fig. 2A). 
The residue at position 110 could also affect ligand stabilization within the active site, which may 
affect the observed product profile. To assess this possibility, we calculated the number of X110-ligand 
atom pairs in interaction (i.e. separated by < 0.5 nm), and the energy associated with the X110-ligand 
interaction. Very few atoms of X110 interacted with DMAPP, in either WT or mutant enzymes. However, 
the number of atom pairs in interaction increased in the presence of GPP and FPP, with a significantly 
higher number of interactions observed for the L110W mutant, but a near absence of GPP-Ala interacting 
atom pairs for the L110A mutant (Fig. 2B). With GPP as ligand, the number of interactions calculated for 
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the Q107F-L110A mutant was intermediate between those of the L110A and Q107F mutants. The main 
contribution to the energy of interaction between X110 and the ligand came from the Van der Waals 
energy term (Lenard-Jones energy), a finding that is consistent with the nature of the side chain of the 
X110 residue and of the allylic backbone of the ligands. The energy of interaction between the X110 
residue and the ligand displayed trends similar to those observed for the number of interacting atom pairs, 
with the highest disparities among mutants observed in the presence of GPP (Fig. 2C). The lowest degree 
of GPP stabilization by the X110 residue was seen with the L110A and Q107F-L110A mutants. The 
replacement of Leu by Ala led to an average decrease of 0.9 kCal/mol in GPP stabilization relative to the 
WT enzyme. Contrastingly, the L110W mutation resulted in a slight increase in GPP stabilization. 
The above results are consistent with observations made by visual inspection of the structures along 
the trajectories. In the WT enzyme bound to GPP, L110 interacted with the ligand and allowed for ligand 
elongation in spite of its bulkiness (Fig. 2D). Replacement of Leu by Ala, suppressed X110-GPP 
interactions and the GPP ligand became wobbly within the active site cavity, presumably due to a lack of 
stabilization (Fig. 2D). This conclusion is further supported by the observation that deformation and 
movement of the GPP ligand along the trajectory were greater for the L110A and Q107F-L110A mutants 
than for the other proteins (Supplemental Figure 4). On the other hand, a Trp residue at position 110 
increased steric hindrance within the cavity, thereby impeding additional condensations (Fig. 2E). In fact, 
production of GPP by the L110W mutant was found to require structural rearrangements (displacement of 
the helix bearing the X110 residue in monomer 1) without which the Trp residue would have made steric 
clashes with the ligand (Fig. 2E). The active site of the L110W mutant could even accommodate an FPP 
molecule, following a change in the orientation of the side chain of the Trp residue and a kink in the 
ligand backbone (Fig. 2F). 
Hydrogen bonds involving the residue at position 107. Q107 was predicted to be the most 
important residue in defining the unique product selectivity of aphid IPPS (Vandermoten et al. 2008a). 
The glutamine amide group would form hydrogen bonds (H-bonds) with other residues of the active site 
cavity, and reorganization of these H-bonds would be required to accommodate longer acyl chains, thus 
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restraining chain elongation. To test this hypothesis, we focused on the H-bonds formed by the residue at 
position 107 (X107) in the WT and mutant structures, without ligand or in the presence of DMAPP, GPP 
or FPP. We found that fourteen distinct residues could compete to make H-bonds with the side-chain of 
X107, at least transiently, in one of the simulated system (Fig. 3A). We classified these bonds as either 
“crossing” or “non-crossing”, depending on whether they involved a partner across the active site cavity 
or not, respectively (Fig. 3A). Four residues out of the fourteen were involved in crossing H-bonds: T172, 
T175, Q179 and/or K209. H-bonds with K209 were further sorted out with respect to the portion of the 
Lys residue (backbone or side chain) involved in the interaction. In the presence of FPP, no crossing H-
bonds were observed (Fig. 3B), which is consistent with the fact that these bonds are not compatible with 
ligand elongation. Since the side-chain of a Phe has neither H-bond acceptor nor donor, no H-bonds were 
detected for the Q107F and Q107F-L110A mutants. 
In the WT enzyme, Q107 made H-bonds approximately half of the time in the absence of ligand or 
in the presence of DMAPP (Fig. 3B). In the structure without ligand, the majority of these H-bonds 
crossed the active site cavity, and K209 was by far the most frequent partner, with interactions involving 
primarily its backbone (Fig. 3C). Presence of a GPP molecule in the active site virtually eliminated H-
bond formation while the FPP ligand allowed these interactions to occur in 15% of the frames, although 
none crossed the cavity (Fig. 3B). 
The replacement of Q107 by a Glu residue led to a ≥ 3-fold increase in the total number of H-bonds 
formed (Fig. 3B). Crossing H-bonds were also more frequent than in the WT enzyme, but only in the 
absence of ligand or in the presence of DMAPP. Again, K209 was the preferred partner, but these 
interactions involved primarily the side chain of K209 (Fig. 3C). 
Differences in the total number of H-bonds were observed between simulations involving the 
L110A mutant and the WT structures. Notably, crossing H-bonds, in the L110A structure, were formed in 
the presence of either DMAPP or GPP (Fig. 3B). In the absence of ligand, Q107 interacted with K209, as 
in the WT enzyme, but made additional H-bonds with Q179; these interactions were maintained 
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following introduction of a DMAPP molecule in the active site (Fig. 3C). In the presence of GPP, most of 
the crossing H-bonds were made with the backbone of K209 (Fig. 3C). 
In the L110W structures with ligand, Q107 made more H-bonds than in the WT enzyme (Fig. 3B). 
This mutation further enhanced the formation of crossing H-bonds in the presence of DMAPP. With a 
GPP molecule in the active site, the frequency of crossing H-bonds rose to an average of 0.95 (Fig. 3B). 
This pronounced increase was mostly due to interactions with T175 and, to a lesser extent, T172 (Fig. 
3C). In the absence of ligand, crossing H-bonds involved primarily the side chains of Q179 and K209. 
The same residues interacted with Q107 in the presence of DMAPP, although the interaction with K209 
involved its backbone instead of its side-chain (Fig. 3C). 
Amongst the H-bonds reported above, the high proportion of interactions between X107 and K209 
(Fig. 3C) suggested that these bonds could play an important role in defining the product selectivity of the 
WT and mutant enzymes, particularly in the case of the Q107E mutant. To further assess this hypothesis, 
we computed the Coulomb energy between these residues along the trajectories. The X107-K209 
electrostatic interactions were consistent with the H-bond profiles of the mutants. For example, the energy 
calculated for the Q107F and Q107F-L110A mutants was 0 kCal/mol, irrespective of the liganded state of 
the enzyme (Fig. 4A,B); this finding concurs with the fact that the Phe residue at position 107 is not polar. 
In the absence of ligand, the Coulomb energy varied between –2.5 and –5 kCal/mol for the WT, L110A 
and L110W structures, whereas it was much lower for the Q107E mutant (–17.8 kCal/mol, on average; 
Fig. 4A,B). This sharp decrease resulted primarily from the formation of salt bridges between the side 
chains of the Glu and Lys residues. In the presence of DMAPP, the Coulomb energy rose to > –2 
kCal/mol for all structures examined except for the Q107E mutant, in which it remained relatively low (–
8.4 kCal/mol; Fig. 4B). In the presence of GPP or FPP, the interactions between Q107 and K209 were 
negligible, as expected from the X107-associated H-bond profiles in these structures. 
Again, visual inspection of the structures along the trajectories corroborated the above observations. 
In the WT enzyme, the H-bonds formed between Q107 and K209 (backbone and side chain) needed to be 
broken to accommodate GPP within the active site, as illustrated by superimposition of unliganded and 
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GPP-liganded structures (Fig. 4C). Substituting Glu for Gln at position 107 led to the formation of a salt 
bridge between E107 and the side chain of K209, the presence of which was not compatible with the 
formation of GPP (Fig. 4D). Interestingly, because the X107 residue is surrounded by two Tyr residues 
(Y106, Y213), the Phe residue in the Q107F mutant could be stabilized through stacking interactions 
between the three aromatic rings. In this position, F107 did not hinder product formation within the active 
site (Fig. 4E). In the L110W mutant, the steric constraint imposed by the Trp residue induced 
displacement of Q107, allowing the formation of specific H-bonds with T172 and T175 in this mutant 
enzyme (Fig. 4F). 
 
DISCUSSION 
Most organisms produce distinct scIPPSs to generate each of the universal C10, C15, and C20 
isoprenoid diphosphate precursors. These prenyltransferases tend to display characteristic residues within 
and near their allylic substrate binding site (FARM), including some that have been shown to play a role 
in product chain-length selectivity. For this reason, the FARM and the residues in its vicinity have been 
designated the “chain-length determination” (CLD) region of scIPPSs (Tarshis et al. 1996). The 
identification of an aphid prenyltransferase that displays dual GPP/FPP synthase activity prompted us to 
take a closer look at its CLD region and to explore the molecular adaptations responsible for its 
uncommon product chain-length selectivity. Here, on the basis of in vitro and in silico characterization of 
WT and site-directed ApIPPS mutants, we identified two residues, located at position –4 (Q107) and –1 
(L110) relative to the FARM, that appear to play a key role in conferring dual activity to the aphid 
enzyme. 
Mechanism conferring dual activity. Product chain-length selectivity of scIPPSs has been 
proposed to be essentially under the control of steric constraints within the active site cavity, with 
residues located upstream from the FARM (Ohnuma et al. 1996a; Ohnuma et al. 1996b; Tarshis et al. 
1996; Narita et al. 1999) and on other α-helices (Chang et al. 2006) being responsible for this effect. As 
supported by our results on the product chain-length selectivity of the designed scIPPS mutants, which are 
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in agreement with our initial predictions and molecular dynamics analyses, the present work shows that 
additional factors can affect product chain-length selectivity. These factors include stabilization of the 
ligand and reorganization of the interactions among residues of the active site cavity upon ligand entry 
and elongation. The latter factor, however, appears to be the most critical one in the aphid enzyme, given 
the atypical nature of the Gln residue at position –4 relative to the FARM, a site that is generally occupied 
by an aromatic residue in FPPSs (Vandermoten et al. 2008a). The polar side-chain of Q107 can indeed 
make H-bonds with residues across the active site cavity, disfavoring the production of longer products. 
Thus, it is not surprising that the Q107E mutation, which converted these H-bonds to more stable salt 
bridges, altered the IPP conversion rate slightly (82%) and the product selectivity in favor of GPP 
production. At position 110, in addition to reducing the IPP conversion rate (52%), substituting Trp for 
Leu increased steric hindrance within the active site, converting the enzyme into a strict GPPS, an 
outcome similar to that reported for avian FPPS following replacement of Ala with Trp at the equivalent 
position (Fernandez et al. 2000). In the aphid enzyme, however, the impact of this Trp residue on steric 
hindrance was enhanced by its indirect effect on the frequency of crossing H-bonds formed by Q107. 
Surprisingly, the L110A mutation, designed to favour FPP formation through a reduction in steric 
hindrance, suppressed enzymatic activity. Although a protein miss-folding problem could be suspected as 
the cause for this lack of activity, this scenario appears very unlikely given that (i) the replacement of Leu 
by Ala constitutes a minor modification of the protein, (ii) an Ala residue is observed at the equivalent 
position in some FPPSs (e.g., avian FPPS) and (iii) the double mutant bearing the exact same substitution 
in addition to a Q107F mutation presented an activity similar to the WT enzyme (97% and 95% IPP 
conversion rate, respectively). In addition, we did not observe any problem with the expression or 
purification of the mutant enzyme (see Supplemental Figure 5 for SDS-PAGE gel). Rather, the absence of 
activity appears to result from a lack of ligand stabilization within the active site cavity. Ala110 would 
indeed not stabilize the ligand enough in the active site to compensate for the need to disrupt Q107-
associated crossing H-bonds for ligand elongation. The latter hypothesis is supported by the fact that 
enzymatic activity was restored in the Q107F-L110A double-mutant, in which Phe107 cannot make H-
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bonds across the active site cavity. Moreover, the product profile of the double-mutant, which generated a 
lower proportion of FPP than the Q107F single mutant, further demonstrates that steric hindrance within 
the active site pocket does not, alone, explain prenyltransferase product chain-length selectivity, and that 
ligand stabilization is also a crucial parameter. 
Functional significance. We do not know whether the product selectivity of the aphid 
prenyltransferase is modulated in vivo to favor the production of either GPP or FPP as a function of the 
desired end product (e.g., mono- or sesquiterpene) in a given tissue. It has been shown, however, that 
under in vitro conditions where the GPP:FPP product ratio was ~1.6:1, rMpIPPS could generate 
significant quantities of both pinene (monoterpene) and germacrene A (sesquiterpene) in a “linked” assay 
where the appropriate terpene synthase was added to the assay buffer (Lewis et al. 2008). As suggested by 
our data, some degree of in vivo modulation of the GPP:FPP product ratio could be achieved by altering 
the local DMAPP concentration, either through regulation of the enzyme responsible of the conversion of 
IPP into DMAPP, IPP isomerase, or enzyme/substrate compartmentalization. The IPP isomerase of the 
aphid A. pisum has been cloned by our group (ApIPPI; Genbank accession no. FJ824667), and, like the 
GPP/FPP synthase studied here, likely contains a N-terminal mitochodrial targeting signal (unpublished 
data). Since both long and short transcripts (e.g., with and without the sequence encoding the 
mitochondrial targeting signal) of the GPP/FPP synthase of M. persicae have been shown to be produced 
(Vandermoten et al. 2008a), the potential exists for the regulation of subcellular localization and 
concentration of each isomerase and synthase and their products. 
Evolutionary origins. It is unclear why evolution would have favored the development of a dual 
GPP/FPP synthase in aphids, as opposed to distinct GPP and FPP synthases in other organisms. Although 
we cannot, at this stage, rule out the existence of such distinct enzymes in the pea aphid, the only clearly 
different prenyltransferase that we were able to identify in this species’ genome through Blast analysis 
(Genbank accession no. XP_001947197) has a sequence that strongly suggests it is a polyprenyl 
diphosphate synthase (e.g., whose product is longer than C20), as opposed to an scIPPS (data not shown). 
These enzymes are typically involved in generating the isoprenyl side chains of coenzyme Q family 
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members, and some use FPP as their allylic diphosphate co-substrate (Tonhosolo et al. 2005), which 
could be provided by the ApIPPS characterized here. 
Although all cis-prenyltransferases, the class of enzymes to which the aphid scIPPS belongs, are 
believed to be derived from a common ancestor (Chen and Poulter 1993), GPPSs appear to be rare in the 
animal kingdom, as plants have a near monopoly on monoterpenes. However, some insects (namely 
aphids and beetles) use monoterpenes as pheromones. Aphids thus require both GPP and FPP as 
precursors for sex pheromone, alarm pheromone and juvenile hormone biosynthesis (Kislow and Edwards 
1972; Schooley and Baker 1985; Dawson et al. 1987), and ApIPPS could well be involved in all of these 
pathways. The first (and only to this day) animal GPPS to have been characterized was cloned from the 
bark beetle Ips pini (IpGPPS), in which distinct GPP and FPP synthases were found (Gilg et al. 2005). 
However, plant GPPSs, which can be either hetero- or homodimeric (Burke et al. 1999; Burke and 
Croteau 2002) and IpGPPS seem to have evolved independently from their respective FPP or GGPP 
synthase precursors (Vandermoten et al. 2009). The product chain-length determination mechanism of 
IpGPPS has not been identified and hypotheses about it cannot be readily proposed given that its CLD 
region is very similar to that of FPPSs (Gilg et al. 2005). Although type-1 lepidopteran FPPSs also 
contain a Gln residue at position −4 relative to the FARM, a phylogenetic analysis that included these and 
several other insect FPPSs and MpIPPS (Cusson et al. 2006) strongly suggests that the two enzymes have 
evolved independently (e.g., within their respective taxon) from a conventional FPPS. In the case of the 
aphid enzyme, this would have occurred through mutations altering the nature of the residue at the fourth 
and, possibly, the first positions upstream from the FARM (some FPPSs already have a Leu residue at 
position –1). Given that these putative mutations would not have suppressed the formation of FPP, it is 
conceivable that they became fixed, without further divergence towards distinct GPP and FPP synthases.  
As indicated above, lepidopteran type-1 FPPS also displays a Gln residue at the fourth position 
upstream from the FARM, but the recombinant enzyme showed neither GPP nor FPP synthase activity in 
the presence of DMAPP and IPP, unless assayed in the presence of the more conventional type-2 protein, 
in which case it enhanced the FPPS activity of the latter enzyme (Sen et al. 2007). In addition, 
17 
 
lepidopteran type-1 FPPS contains several other uncommon active-site substitutions relative to other 
IPPSs, some of which are expected to interact with the Gln residue in ways that are different from those 
identified here for the aphid enzyme. Finally, the production of monoterpenes by lepidopteran insects 
seems rare as it has been reported only once (Vandermoten et al. 2008b). However, many coleopteran 
insects share with aphids an ability to produce both mono- and sesquiterpenoid compounds, and could 
therefore have independently acquired an scIPPS with features similar to those described here for the 
aphid enzyme. Whether there exist IPPSs displaying similar features and product chain-length 
determination mechanisms in other insect taxa has yet to be established. 
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FIGURE LEGENDS 
Fig. 1. A) Alignment of ApIPPS and MpIPPS amino acid residues 106 to 115, along with the 
corresponding region of chicken FPPS (GgFPPS), for comparison; arrows point to the two residues 
chosen for mutagenesis. B) Radio-HPLC analysis of in vitro products (GPP and FPP) of WT rApIPPS, 
following 40 min incubation at 37°C, in the presence of 4 µM [14C]IPP and increasing concentrations of 
DMAPP, and conversion of the products to their corresponding alcohols. C) Same as in B, but for WT 
and all mutant proteins assayed at 10 µM DMAPP. The L110A mutant displayed no detectable activity. 
 
Fig. 2. Interactions between residues at position 110 (X110) and ligands, as determined during 3.5 ns 
molecular dynamics simulations (from 500 to 4000 ps). A) Minimum distance (mean ± SD; nm) between 
X110 and the ligand, computed for both subunits. B) Number of X110-ligand atom pairs (mean ± SD) 
less than 5 nm apart, computed for both subunits. C) Evolution of the Lennard-Jones energy (kCal/mol) 
between X110 and GPP along the trajectories in one subunit. D-F) Representative snapshots of the active 
site cavity. The X110 residue and the ligand are shown as sticks, while the α-helix bearing the X110 
residue is displayed as a ribbon. Hydrogen atoms are omitted. In all cases, dimeric structures were 
superimposed using the WT structure as reference. 
 
Fig. 3. H-bonds involving the residue at position 107 (X107) and other residues within the active site, as 
determined during 3.5 ns molecular dynamics simulations (from 500 to 4000 ps). A) Stereo view of a 
snapshot of the WT enzyme showing the fourteen residues that could make crossing (colored) and non-
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crossing (grey; light-grey in the case of the tyrosine residue shown behind the space-fill FPP molecule) 
H-bonds with X107 along the trajectories. Dashed lines denote pairs of residues that can make crossing 
H-bonds. L110 is also displayed (black). Hydrogen atoms are omitted. B) Average frequency of 
occurrence of crossing, non-crossing and total H-bonds between the side chain of X107 and any other 
residue, computed for both subunits. C) Frequency of occurrence of H-bonds formed between X107 and 
K209/side-chain, K209/backbone, Q179, T175 and T172 (average for two monomers). 
 
Fig. 4. Specific interactions between the residue at position 107 (X107) and K209, as determined during 
3.5 ns molecular dynamics simulations (from 500 to 4000 ps). A) Evolution of the Coulomb energy 
between X107 and K209 in one subunit during the simulation, without ligand. B) Mean coulomb energy 
(± SD) between X107 and K209 for both subunits. C-F) Representative snapshots of the active site cavity. 
For reasons of clarity, only selected residues from one subunit are shown. Hydrogen atoms are omitted 
and H-bonds are represented by dashed lines. In all cases, dimeric structures were superimposed using the 
WT structure with GPP as reference. 
